Breaking News from WHO Executive Board Session in Geneva – WFH
World Federation of Hemophilia shared a post on LinkedIn:
“Breaking News from WHO Executive Board Session in Geneva!
Today the World Health Organization Executive Board EB158 approved the decision to recommend adoption of the resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders at the 79th World Health Assembly (WHA) in May 2026!
This decision marks a vital step forward toward the final adoption of this resolution in May, leading to greater health equity for people with Bleeding Disorders.
The World Federation of Hemophilia would like to especially acknowledge the unwavering leadership of the Republic of Armenia, and all co-sponsoring Member States including Bosnia & Herzegovina, Egypt, Georgia, Iraq, Latvia, Malta, Morocco, Nepal, Paraguay, Spain, Sri Lanka and Togo, and to over 80 patient and medical associations who have joined the WFH’s Global Call for Health Equity for Bleeding Disorders in support of this resolution!
Stay tuned for more updates from the WFH in coming days and weeks on the next steps towards final adoption of the resolution at the 79th World Health Assembly in May 2026.”
Harshal Kale, Regional Program Manager of South Asia and East Asia at World Federation of Hemophilia, shared this post, adding:
“A meaningful step forward as the WHO Executive Board recommends adoption of the Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders (EB158) at the World Health Assembly in May 2026.
Proud to have contributed to regional advocacy efforts securing co-sponsorships from Nepal and Sri Lanka. Grateful to Armenia and all the supporting Member states, patient organisations, and medical associations for driving this global call to action.”
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS